Gwendolyn Wu
Senior reporterGwendolyn is a senior reporter at BioPharma Dive covering biotech startups, venture capital and the ecosystem that supports them. Previously, she authored Bay Briefing, the San Francisco Chronicle’s flagship weekday newsletter, and covered COVID-19 and the business of healthcare for the Houston Chronicle. Outside of the newsroom, Gwendolyn teaches at the California Scholastic Press Association summer workshop for high school journalists, and has led student and early career programs for the Asian American Journalists Association. She has degrees in history and sociology from the University of California at Santa Barbara.
316 articles by Gwendolyn Wu
-
Strand raises another $153M to make ‘programmable’ mRNA drugs
Aug. 7, 2025 -
Xoma strikes deals to buy struggling biotechs HilleVax, Lava
Aug. 4, 2025 -
Venture firm Frazier closes $1.3B fund for early-stage biotech investing
July 31, 2025 -
Radiopharma startup Artbio secures $132M to fund testing of Pluvicto rival
July 29, 2025 -
Bristol Myers shuffles its executive ranks with new CMO
July 25, 2025 -
A TCG offshoot pulls in $400M for biotech startup creation
July 24, 2025 -
Biotech startup funding dried up in second quarter, HSBC finds
July 17, 2025 -
AstraZeneca rare disease drug fails key trial tests
July 16, 2025 -
Renasant Bio, chasing drugs for ADPKD, raises $55M in seed funding
July 10, 2025 -
Actithera draws new investors to radiopharma drug pitch
July 9, 2025 -
Protein degraders: chasing undruggable targets
July 8, 2025 -
Study results boost Cogent’s case for rare disease drug
July 7, 2025 -
Sage to lay off most staff amid Supernus buyout
June 30, 2025 -
Vor, with new CEO, changes course to target autoimmune disease
June 26, 2025 -
Kymera adds Gilead as research partner, while advancing new candidate with Sanofi
June 25, 2025 -
Lexeo to help launch spinout around RNA drugs for the heart
June 24, 2025 -
A longer ‘winter’: Public funding slowdown heightens pressure on biotech startups
June 20, 2025 -
Draig, a brain drug startup, debuts with $140M to treat depression
June 18, 2025 -
A startup banks $66M to pursue ‘inclusive precision medicine’
June 18, 2025 -
SpliceBio lands $135M for a new kind of eye gene therapy
June 11, 2025 -
National Resilience, a well-funded manufacturing startup, to scale back operations
June 10, 2025 -
Kymera, with new data, takes early step toward a Dupixent-like pill
June 2, 2025 -
Cancer drugmaker iTeos to shut down
May 28, 2025 -
GlycoEra raises $130M, riding interest in protein degraders
May 27, 2025 -
Prime Medicine claims ‘proof of concept,’ but lays off staff in pivot
May 19, 2025